Friday, April 10, 2015

Tianjin Zhongxin

Tianjin Zhongxin: Shooting to a new high, gaining 11.6% today. The stock is dual-listed on Shanghai and Singapore, and the Singapore-listed (denom in USD) is currently trading at 63% discount to its A-share.

Tianjin Zhongxin's flagship product, Su Xiao Jiu Xin pills is a household name in China for cardio-vascular ailment, and CIMB said on 31 Mar that a major shareholder is taking advantage of the huge price gap between A- and S-shares, to restore its stake in the company via buying S-shares, in anticipation of the dilution from the A-share placement.

CIMB has TP of $1.45.

No comments:

Post a Comment